Latest News
Featured News
Select the category
Preliminary Results for the year ended 30 April 2026
Publication of Circular, Notice of General Meeting and Proposed Share Consolidation
Scancell completes up to US$25 million in debt financing
Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced Melanoma
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.